Galectin-3 in Heart Failure with Preserved Ejection Fraction: A RELAX Trial Substudy

OBJECTIVE: We hypothesized that elevated Galectin-3 (Gal-3) levels would identify patients with more advanced heart failure (HF) with preserved ejection fraction (HFpEF) as assessed by key pathophysiologic domains. BACKGROUND: Gal-3 is implicated in the pathogenesis of cardiac fibrosis but is also i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JACC Heart Fail
Main Authors: AbouEzzeddine, Omar F., Haines, Phillip, Stevens, Susanna, Nativi-Nicolau, Jose, Felker, G Michael, Borlaug, Barry A., Chen, Horng H., Tracy, Russell P., Braunwald, Eugene, Redfield, Margaret M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4369675/
https://ncbi.nlm.nih.gov/pubmed/25742762
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jchf.2014.10.009
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados